OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals
Rama Rao Malla, KGK Deepak, Neha Merchant, et al.
Phytomedicine (2020) Vol. 70, pp. 153227-153227
Closed Access | Times Cited: 22

Showing 22 citing articles:

HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
G. Seeta Rama Raju, E. Pavitra, Sai Samyuktha Bandaru, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 53

Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment
Rama Rao Malla, Nagalakshmi Surepalli, Batoul Farran, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 160, pp. 103285-103285
Closed Access | Times Cited: 64

Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
Ye Cao, Fansu Meng, Tiange Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 5

Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
Rama Rao Malla, Rakshmitha Marni, Anindita Chakraborty, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 2, pp. 221-231
Open Access | Times Cited: 37

Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 36

Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23

Tumor microenvironment pathways: Cross regulation in breast cancer metastasis
Rama Rao Malla, P. Janardhana Kiran
Genes & Diseases (2020) Vol. 9, Iss. 2, pp. 310-324
Open Access | Times Cited: 35

Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway
Peng Li, Zhiping Lin, Qianzheng Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25

Plant extract from Caesalpinia spinosa inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model
M Jiménez, Karol Prieto, Paola Lasso, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14148-e14148
Open Access | Times Cited: 6

Tumor Microenvironment: Multiway Role in Drug Resistance
Ishfaq Majid Hurra, Mubashir J. Mintoo, Kaneez Fatima, et al.
(2024), pp. 153-181
Closed Access | Times Cited: 1

Antiproliferative and Apoptotic Effects of pH‐Responsive Veratric Acid‐Loaded Polydopamine Nanoparticles in Human Triple Negative Breast Cancer Cells
Ganesh Harini, S. Shree Ganesh, Ramprasad Anushikaa, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 4

Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights
Mohammed H. Qusa, Khaldoun S. Abdelwahed, Abu Bakar Siddique, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1706-1706
Open Access | Times Cited: 11

CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
Yi Chun Pan, Tomoyuki Nishikawa, Chin Yang Chang, et al.
Molecular Therapy — Oncolytics (2020) Vol. 20, pp. 175-186
Open Access | Times Cited: 11

Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies
Rama Rao Malla, Durga Bhavani Kundrapu, Priyamvada Bhamidipati, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5728-5728
Open Access | Times Cited: 2

Hepatoprotective activity and free radical scavenging against induction of CCl4 in an experimental model using dendronaphthya crude extract loaded chitosan nanocarrier
Nada Ismail, Kamel R. Shoueir, El‐Shahat A. Toson
Journal of Drug Delivery Science and Technology (2021) Vol. 66, pp. 102906-102906
Open Access | Times Cited: 6

Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
Amiya Das, Pallavi Agarwal, Gaurav Jain, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 515-550
Closed Access | Times Cited: 5

Multifaceted role of phytoconstituents based nano drug delivery systems in combating TNBC: A paradigm shift from chemical to natural
Anandita Nair, Roshni Singh, Namrata Gautam, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9207-9226
Closed Access

Plant‐Derived Phytochemicals and Their Nanoformulations for Inducing Programed Cell Death in Cancer
Haoyu Wang, Xiaoyang Wang, Long Wang, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 10
Closed Access

Phytonutraceuticals in Cancer Prevention and Therapeutics
Shailaja Dombe, Pramodkumar J. Shirote
Current Nutrition & Food Science (2022) Vol. 19, Iss. 3, pp. 209-228
Closed Access | Times Cited: 3

High-throughput, Label-free Proteomics Identifies Salient Proteins and Genes in MDA-MB-231 Cells Treated with Natural Neem-based Electrochemotherapy
Gowrisree Varadarajan, Jeya Shree Thulasidas, Pragatheiswar Giri, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 1, pp. 148-166
Closed Access | Times Cited: 2

Page 1

Scroll to top